Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Manipulating the Microbiome in IBD by Antibiotics and Fecal Microbiota Transplantation (FMT)
NCT02033408Completed
- Sponsor
- Shaare Zedek Medical Center
- Start
- Jan 2014
- Primary completion
- Dec 2018
- Modality
- Nanoparticles, Implantable Devices, Cyclic Peptides
- Countries
- 6
01
Overview
Randomised, open-label trial of vancomycin, amoxicillin, metronidazole, doxycycline, ciprofloxacin and 2 more in ulcerative colitis (UC) and Crohn's colitis (3 arms), sponsored by Shaare Zedek Medical Center. Primary endpoint: Pediatric Ulcerative Colitis Activity Index at 5 days. Started Jan 2014; status: completed.
02
Drugs
vancomycinamoxicillinmetronidazoledoxycyclineciprofloxacin
03
Conditions
ulcerative colitis (UC)Crohn's colitis
Beyond the preview
Go deeper on NCT02033408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02033408.